









시장가
/
주식
/
nasdaq-celz
/

Creative Medical Technology Holdings Inc

CELZ

3.510USD

0.000

종가 09/19, 16:00（ET）시세는 15분 지연됩니다

9.06M시가총액

손실P/E TTM



Creative Medical Technology Holdings Inc

3.510

0.000

개요 회사 금융 분석

분석

자세한 내용은 Creative Medical Technology Holdings Inc 회사

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.

회사 정보

종목 코드 CELZ

회사 이름Creative Medical Technology Holdings Inc

상장일May 01, 2009

CEOMr. Timothy Warbington

직원 수4

유형Ordinary Share

회계 연도 종료May 01

주소211 E. Osborn Rd.

도시PHOENIX

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호85012

전화14803992822

웹사이트https://creativemedicaltechnology.com/

종목 코드 CELZ

상장일May 01, 2009

CEOMr. Timothy Warbington

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Timothy Warbington

President, Chief Executive Officer, Director

12.21K

Mr. Donald Dickerson

Chief Financial Officer, Senior Vice President, Director

17.00

Mr. Michael H. Finger

Independent Director

Mr. Bruce S. Urdang, Esq.

Independent Director

Ms. Susan Hegarty Snow

Independent Director

이름

이름/직위

직위

주식 보유

변동

Mr. Timothy Warbington

President, Chief Executive Officer, Director

12.21K

Mr. Donald Dickerson

Chief Financial Officer, Senior Vice President, Director

17.00

Mr. Michael H. Finger

Independent Director

Mr. Bruce S. Urdang, Esq.

Independent Director

Ms. Susan Hegarty Snow

Independent Director

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sat, Sep 6

주주

주주 유형

주주

비율

Creative Medical Health, Inc.

0.88%

Geode Capital Management, L.L.C.

0.81%

The Vanguard Group, Inc.

0.68%

Warbington (Timothy)

0.47%

Citadel Advisors LLC

0.43%

기타

96.72%

주주

비율

Creative Medical Health, Inc.

0.88%

Geode Capital Management, L.L.C.

0.81%

The Vanguard Group, Inc.

0.68%

Warbington (Timothy)

0.47%

Citadel Advisors LLC

0.43%

기타

96.72%

주주 유형

주주

비율

Investment Advisor

1.43%

Corporation

0.88%

Investment Advisor/Hedge Fund

0.88%

Individual Investor

0.49%

Hedge Fund

0.47%

기타

95.86%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

242.47K

9.38%

+92.22K

2025Q1

239.16K

9.28%

+93.67K

2024Q4

67.44K

3.86%

-172.00K

2024Q3

114.73K

8.54%

-150.07K

2024Q2

115.50K

8.55%

-269.83K

2024Q1

151.46K

11.09%

-154.43K

2023Q4

64.97K

4.67%

-273.04K

2023Q3

127.49K

15.08%

-223.19K

2023Q2

127.02K

15.07%

-210.98K

2023Q1

140.30K

16.02%

-112.96K

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Creative Medical Health, Inc.

22.70K

0.88%

Apr 15, 2025

Geode Capital Management, L.L.C.

18.27K

0.71%

+7.96K

+77.22%

Mar 31, 2025

The Vanguard Group, Inc.

17.63K

0.68%

Mar 31, 2025

Warbington (Timothy)

12.21K

0.47%

Apr 15, 2025

Northern Trust Investments, Inc.

805.00

0.03%

+805.00

Dec 31, 2023